The GLP-1 Cost Problem: Bigger Than Most Employers Realize GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound have reshaped the treatment landscape for both diabetes and obesity
Monosodium glutamate (C5H9NO4 Na
Last reviewed: July 3, 2026 Last updated: July 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The effectiveness of the Calibrate program for weight loss has been demonstrated through available evidence and positive user outcomes, making it a promising option for those seeking sustainable results
The only primary-source injectable AHK-Cu-class dose range animal / formulation data, not a human trial
A causal link between prediction errors, dopamine neurons and learning